Jae Cheol Lee

This inventor holds 8 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Samsung Sds, Lg Electronics Inc., Oncobix Co., Ltd.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae Cheol Lee. Retrieved from https://idiyas.com/inventor/jae-cheol-lee-gevup2t7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 11)

% Patents Active = 37.5

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)

Location History:

Osan-si, KR (2010)
Seoul, KR (2007 - 2022)

Company Filing History:

Samsung Sds Co., Ltd.

patents

Years Active: 2007-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12737337 - Method and system for identifying grid format object in robotic process automation environment (2026-09-15),

2. 12737203 - Method of optimizing execution of RPA bot (2026-09-15),

3. 12645489 - Method for robotic process automation, apparatus and system for executing the method (2026-06-02),

4. 12547434 - Method for recording and executing RPA task (2026-02-10),

5. 12386661 - Apparatus and method for executing automation scenario in parallel (2025-08-12),

6. 11248003 - Pyrimidine derivative having effect of inhibiting cancer cell growth and pharmaceutical composition containing same (2022-02-15),

7. 7710843 - Method and apparatus for supporting fast finalization for a recording medium (2010-05-04),

8. 7308238 - Automatic frequency controlling apparatus and method of mobile communication terminal (2007-12-11),

Title: Innovations of Jae Cheol Lee

Introduction

Jae Cheol Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the fields of automation and pharmaceuticals, holding a total of 8 patents. His work focuses on developing innovative solutions that address complex challenges in technology and healthcare.

Latest Patents

One of Jae Cheol Lee's latest patents is an "Apparatus and method for executing automation scenario in parallel." This invention includes a section extraction module that receives an automation scenario with multiple sections and extracts sections that can be executed in parallel. It also features a section optimization module that generates a parallel execution section list based on predetermined priorities for various job types. Additionally, a job scheduler is included to create an idle bot list, matching idle bots to the sections based on expected execution times and priorities.

Another notable patent is for a "Pyrimidine derivative having effect of inhibiting cancer cell growth and pharmaceutical composition containing same." This innovative compound effectively inhibits the growth of cancer cells that express the C797S mutant EGFR and are MET-amplified, which are known resistance mechanisms against third-generation EGFR anticancer agents. This discovery holds promise for the treatment of lung cancer.

Career Highlights

Jae Cheol Lee has worked with notable companies such as LG Electronics Inc. and Oncobix Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking projects in technology and medicine.

Collaborations

Throughout his career, Jae Cheol Lee has collaborated with talented individuals, including coworkers Sung-Eun Kim and Sunho Lee. These partnerships have fostered a creative environment that encourages innovation and the development of new ideas.

Conclusion

Jae Cheol Lee's contributions to automation and pharmaceuticals demonstrate his commitment to innovation and problem-solving. His patents reflect a deep understanding of complex systems and a desire to improve lives through technology. His work continues to inspire future advancements in these fields.

Profile summary based on public USPTO records.